Safety, Efficacy, and Pharmacokinetics of Flebogamma® 5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases

Author: Berger Melvin   Pinciaro Paul J.    

Publisher: Springer Publishing Company

ISSN: 0271-9142

Source: Journal of Clinical Immunology, Vol.24, Iss.4, 2004-07, pp. : 389-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content